Department of Immunology
The Dr. William Huebsch Professorship in Immunology
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo New York USA 14263
Tel: 716 - 845 - 3288
Fax: 716 - 845 - 8906
E-mail: elizabeth.repasky@roswellpark.org

Lab Website: www.roswellpark.org/repasky_lab

Current Program

• Evaluation of novel  strategies that enhance anti-tumor immunity and direct tumor cell killing.
• Understanding the role of temperature and heat shock proteins in lymphocyte and dendritic cell activation  and immune effector activity; 
• Manipulation of thermoregulation for enhanced delivery of cancer therapeutics

For a list of Dr. Repasky's publications, please click here for a complete list through PubMed.

Biography

Dr. Elizabeth A. Repasky joined the staff of Roswell Park Cancer Institute (RPCI) in 1983, as Cancer Research Scientist, Department of Immunology. She also is Director of Graduate Studies and Professor, Immunology Program, Roswell Park Graduate Division, University at Buffalo.

Dr. Repasky earned her doctoral degree in Anatomy at the University at Buffalo in 1981, and completed postdoctoral fellowship training in Cell Biology at the California Institute of Technology, Pasadena, CA, in 1982.

Dr. Repasky’s laboratory research program focuses on tumor and cellular immunology and the development of improved biological therapies, including vaccines for cancer treatment. She works on the cell biology of lymphocyte activation and, in particular, the effects of fever-like whole body hyperthermia treatments and heat shock proteins on the antitumor immune response. Clinical research studies include analysis of immune responses in cancer survivors, Phase I/II studies using whole-body hyperthermia in combination with various other cancer therapies, and evaluation of new vaccines for solid tumors.

Dr. Repasky is a member of the American Association for Cell Biology, Society of Leukocyte Biology, Society for Biologic Therapy, and North American Hyperthermia Society. Currently, she serves as a member of the Council for the Society for Biologic Therapy, the Council of the Biology Section, North American Hyperthermia Society, and of RPCI’s Scientific Affairs Council.

Dr. Repasky has been issued patents for the Use of Milk Fat Globules as Carriers for Drugs (1991); Microflotation Devices Used for Immunoassays and Cell/Molecular Fractionation (1991); and a Murine Model for Human Carcinoma (1999). Dr. Repasky has authored or co-authored more than 100 journal publications, book chapters and abstracts. She is a member of the Editorial Board of the International Journal of Hyperthermia.